Variant report
Variant | nsv613419 |
---|---|
Chromosome Location | chr9:11187028-11235126 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-3 | chr9:11194276-11194381 | XLOC_007645 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000054392 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530074699 | chr9:11194001-11194002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546691615 | chr9:11194005-11194006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142327480 | chr9:11194014-11194015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111539129 | chr9:11194029-11194030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139000159 | chr9:11194052-11194053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572830390 | chr9:11194055-11194056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10125755 | chr9:11194115-11194116 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs565524260 | chr9:11194117-11194118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7465994 | chr9:11194132-11194133 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs142144714 | chr9:11194149-11194150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567240831 | chr9:11194186-11194187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73403199 | chr9:11194222-11194223 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs543906249 | chr9:11194236-11194237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10809379 | chr9:11194239-11194240 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs146350328 | chr9:11194292-11194293 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs529327323 | chr9:11194334-11194335 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs559192111 | chr9:11194348-11194349 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs7862633 | chr9:11194352-11194353 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs184585062 | chr9:11194353-11194354 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs148137633 | chr9:11194389-11194390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78779604 | chr9:11194411-11194412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561530235 | chr9:11194425-11194426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188785023 | chr9:11194438-11194439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74577153 | chr9:11194499-11194500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141707192 | chr9:11194526-11194527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376687726 | chr9:11194532-11194533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201418930 | chr9:11194539-11194540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1489171 | chr9:11194546-11194547 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs10809380 | chr9:11194626-11194627 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs192903087 | chr9:11194657-11194658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569020957 | chr9:11194670-11194671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34626918 | chr9:11194716-11194717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530588397 | chr9:11194785-11194786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371033110 | chr9:11194831-11194832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185859026 | chr9:11194837-11194838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530973857 | chr9:11194842-11194843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567201845 | chr9:11194851-11194852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550670165 | chr9:11194856-11194857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10756202 | chr9:11194921-11194922 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs566392878 | chr9:11194931-11194932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527751425 | chr9:11194935-11194936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150530516 | chr9:11194991-11194992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527879913 | chr9:11194994-11194995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558644424 | chr9:11195009-11195010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575427134 | chr9:11195117-11195118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544786653 | chr9:11195146-11195147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552583344 | chr9:11195177-11195178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555226599 | chr9:11195189-11195190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139481948 | chr9:11195208-11195209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540608396 | chr9:11195269-11195270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11194000-11194600 | Enhancers | Fetal Brain Male | brain |
2 | chr9:11194200-11194400 | Enhancers | Brain Germinal Matrix | brain |
3 | chr9:11194200-11195000 | Enhancers | Fetal Brain Female | brain |
4 | chr9:11194400-11195200 | Weak transcription | Brain Germinal Matrix | brain |
5 | chr9:11195200-11196200 | Enhancers | Brain Germinal Matrix | brain |
6 | chr9:11196000-11196800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr9:11196800-11197200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr9:11197200-11203000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr9:11199000-11199800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr9:11199200-11199800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr9:11199200-11199800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr9:11199200-11200400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr9:11199400-11199800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr9:11199600-11200400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr9:11207600-11207800 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
16 | chr9:11233800-11235200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr9:11234600-11235800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |